{{Rsnum
|rsid=2233945
|Gene=PSORS1C1
|Chromosome=6
|position=31139584
|Orientation=minus
|GMAF=0.1221
|Gene_s=PSORS1C1,PSORS1C2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 70.8 | 25.7 | 3.5
| HCB | 86.1 | 13.1 | 0.7
| JPT | 97.3 | 2.7 | 0.0
| YRI | 74.8 | 25.2 | 0.0
| ASW | 82.5 | 15.8 | 1.8
| CHB | 86.1 | 13.1 | 0.7
| CHD | 89.9 | 10.1 | 0.0
| GIH | 85.1 | 13.9 | 1.0
| LWK | 66.4 | 29.1 | 4.5
| MEX | 79.3 | 20.7 | 0.0
| MKK | 59.0 | 36.5 | 4.5
| TSI | 69.6 | 24.5 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=24322967
|Title=HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}